|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 22 July 2022, 9:00. The announcement is marked as price sensitive, and is 2 page(s) in length and 197.54kb in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.002% short sold according to ASIC data. It was ranked the 630th most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| hTERT US Patent Granted | 22 July 2022, 9:00 |
| INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out | 21 July 2022, 8:46 |
| SubB2M US Patent Grant and Program Update | 1 July 2022, 9:53 |
| INOVIQ&University of Sydney Present New EXO-NET Data at ISEV | 27 May 2022, 9:37 |
You must be logged in to post a reply.
